Scopus by Title (Ref)
Articles that cite the referenced work, matched by title from the Scopus database.
Targeting Gut Microbiota by DPP-4 Inhibitors in Obesity: Mechanistic Insights and Therapeutic Implications
Current Nutrition Reports
December 2026
Alanazi M.
Pyridazine- and triazine–acetophenone derivatives: synthesis, crystal structure, Hirshfeld surface, DFT analysis, and multitarget docking against DPP-4/CYP7A1/GSK-3β
Journal of Molecular Structure
25 August 2026
Singh R.R.P.
Novel triazole-based piperidine DPP-4 inhibitors with potent anti-diabetic activity: design, synthesis, and biological evaluation
Results in Chemistry
15 July 2026
Pourbaba Y.
Open Access
SM-GAT: a safety-aware multi-task graph attention network for multi-target anti-diabetic lead discovery from natural products
Frontiers in Molecular Biosciences
8 July 2026
Zhang J.
Open Access
Structure-Based in Silico Insights of Sitagliptin Analogs against Dipeptidyl Peptidase-4
Biomedical and Pharmacology Journal
June 2026
Sahib H.A.
Open Access
Unveiling the conformational analysis of N/S-methylene-N/S linked symmetrical scaffolds of 1,2-pyridazinone and 1,2,4-triazinone derivatives: DPP-4 inhibitors
Journal of Molecular Structure
25 April 2026
Kumar V.
GPU-Accelerated Virtual Screening and Molecular Dynamics Simulations for Identification of Novel DPP-4 Inhibitors
ACS Omega
3 February 2026
Vasquez-Martínez N.
Open Access
Design, synthesis, and multi-target biological evaluation of 1,2,3-triazole linked indole–thiazolidinedione hybrids as potent α-glucosidase, α-amylase, and DPP-4 inhibitors with antioxidant potential
Journal of Molecular Structure
5 January 2026
Sharma A.
Coumarin derivatives as antidiabetic agents: a comprehensive review on mechanistic insights, structure-activity relationships, in silico studies, and challenges
Future Medicinal Chemistry
2026
Verma S.
All Open Access, Green
Long-Term Safety of Dpp-4 Inhibitors: An Insight from Clinical Trials and Real-World Evidence
International Journal of Drug Delivery Technology
2026
Nematullah M.
Open Access
Spiropyrrolizine derivatives as multitarget antidiabetic agents in obese type 2 diabetes: integrated in silico, in vitro, and in vivo evaluation of DPP-4 inhibition and hepatic enzyme modulation
Future Medicinal Chemistry
2026
Abdella F.I.A.
All Open Access, Green
Brown adipose tissue: a potential therapeutic target for preventing cardiovascular disease in metabolic disorders
Diabetology and Metabolic Syndrome
December 2025
Egan Beňová T.
Open Access
Potential Molecular Biomarkers for Predicting and Monitoring Complications in Type 2 Diabetes Mellitus
Molecules
November 2025
Shariat-Madar Z.
Open Access
Unlocking the Potential of Pyrrolidine Derivatives as Antidiabetic Agents: Insights from Physicochemical Analysis, Molecular Docking, ADMET, and DFT Studies
Chemistryselect
6 October 2025
Ahmad Bhat A.
Unraveling the Antihyperglycemic Effects of Dipeptyl Peptidase-4 Inhibitors in Rodents: A Multi-Faceted Approach Combining Effects on Glucose Homeostasis, Molecular Docking, and ADMET Profiling
Pharmaceuticals
October 2025
Roriz R.N.S.
Open Access
Design, Synthesis and Antidiabetic Activity of Novel Pyrrole-3-Carboximidamide Derivatives as Dipeptidyl Peptidase-4 Inhibitors
Archiv Der Pharmazie
August 2025
Dastjerdi H.F.
Open Access
Inhibitors of Proteases: A Well-Grounded Strategy in Drug Development
Molecules
July 2025
Previti S.
Open Access
Effect of Kaempferia galanga L. on Xanthine Oxidase Activity and Arterial Stiffness in Hyperuricemia
Tropical Journal of Natural Product Research
28 February 2025
Hasimun P.
Open Access
Unveiling the research directions for pyrrolidine-based small molecules as versatile antidiabetic and anticancer agents
Future Medicinal Chemistry
2025
Kumar S.
All Open Access, Green
Sarcopenia and Muscle Metabolism in Cardiovascular–Kidney–Metabolic Syndrome: Pathophysiology, Clinical Implications, and Therapeutic Strategies
Cardiovascular Kidney Metabolic Syndrome
1 January 2025
Ilie A.C.
Exploring the pharmacological versatility of triazolopyrazine: A multi-target scaffold for drug development
Future Medicinal Chemistry
2025
Mondal D.